Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506045 · ClinicalTrials.gov registry record
Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device
A clinical trial, sponsored by Rhaeos.
- Terminated
- Registry status
- 10
- Enrollment target
NCT06506045: Clinical Trial study, sponsored by Rhaeos.
NCT06506045 is a clinical trial that was terminated before completion, run by Rhaeos. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06506045 was terminated before completion, sponsored by Rhaeos.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of known non-functional and functional implanted shunts will assess the diagnostic non-inferiority of the second-generation device to the first-generation device.
Primary Outcome
Study device sensitivity will be calculated as TP / (TP + FN).
Interventions
- DEVICE FlowSense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-07-27 |
| Est. Completion | 2024-07-27 |
Why NCT06506045 stopped before completion
NCT06506045 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FlowSense is the first listed.
NCT06506045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06506045 about?
NCT06506045 is a clinical study titled "Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device". This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of known non-functional and functional implanted shunts will assess the diagnostic non-inferiority of the second-generation device to the first-generation devi...
What is the current status of trial NCT06506045?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2024-07-27. Estimated completion is 2024-07-27.
What interventions are being tested in trial NCT06506045?
The interventions under investigation include: FlowSense (DEVICE).
Who is sponsoring clinical trial NCT06506045?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI